Synergistic effect of anti and pro-inflammatory cytokine genes and their promoter polymorphism with ST-elevation of myocardial infarction

Gene

Volumn 544, Issue 2, 2014, Pages 145-151

  Biswas, Santanu ^a   Ghoshal, Pradip Kumar ^b   Mandal, Nripendranath ^a  

^a BOSE INSTITUTE   (India)

^b NRS MEDICAL COLLEGE   (India)

Author keywords

Gene gene interactions; Interleukins; Polymorphism; STEMI

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CASE CONTROL STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE INTERACTION; GENOTYPE; HUMAN; INFLAMMATION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION MAPPING; SINGLE NUCLEOTIDE POLYMORPHISM; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

GENE-GENE INTERACTIONS; INTERLEUKINS; POLYMORPHISM; STEMI;

ADULT; AGED; ATHEROSCLEROSIS; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INFLAMMATION; INTERLEUKIN-10; INTERLEUKIN-6; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; SMOKING; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84900494997     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2014.04.065     Document Type: Article

References (44)

1. Antonicelli R., Olivieri F., Cavallone L., et al. Tumor necrosis factor-alpha gene -308G>A polymorphism is associated with ST-elevation myocardial infarction and with high plasma levels of biochemical ischemia markers. Coronary Artery Disease 2005, 16:489-493.
2. Antonicelli R., Olivieri F., Bonafe' M., et al. The interleukin-6 -174G>C promoter polymorphism is associated with an higher risk of death after an acute coronary syndrome in male elderly patients. International Journal of Cardiology 2005, 103:266-271.
3. Balkwill F. Tumor necrosis factor or tumor promoting factor?. Cytokine and Growth Factor Reviews 2002, 13:135-141.
4. Barath P., Fishbein M.C., Cao J., Berenson J., Helfant R.H., Forrester J.S. Detection and localization of tumor necrosis factor in human atheroma. American Journal of Cardiology 1990, 65:297-302.
5. Bennermo M., Held C., Green F., et al. Prognostic value of plasma interleukin-6 concentrations and the -174G>C and -572G>C promoter polymorphisms of the interleukin-6 gene in patients with acute myocardial infarction treated with thrombolysis. Atherosclerosis 2004, 174:157-163.
6. Biswas S., Ghoshal P.K., Mandal S.C., Mandal N. Relation of anti- to pro-inflammatory cytokine ratios with acute myocardial infarction. Korean Journal of Internal Medicine 2010, 25:44-50.
7. Bowcock A.M., Kidd J.R., Lathrop G.M., et al. The human "interferon-b2 hepatocyte stimulating factor interleukin-6" gene: DNA polymorphism studies and localization to chromosome 7p21. Genomics 1988, 3:8-16.
8. Burzotta F., Iacoviello L., Di Castelnuovo A., et al. Relation of the -174G/C polymorphism of interleukin-6 to interleukin-6 plasma levels and to length of hospitalization after surgical coronary revascularization. American Journal of Cardiology 2001, 88:1125-1128.
9. Eskdale J., Kube D., Tesch H., Gallagher G. Mapping of the human IL10 gene and further characterization of the 5'-flanking sequence. Immunogenetics 1997, 46:120-128.
10. Fishman D., Faulds G., Jeffery R., et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. Journal of Clinical Investigation 1998, 102:1369-1376.
11. Frangogiannis N.G., Smith C.W., Entman M.L. The inflammatory response in myocardial infarction. Cardiovascular Research 2002, 53:31-47.
12. Heijmans B.T., Westendorp R.G., Droog S., Kluft C., Knook D.L., Slagboom P.E. Association of the tumour necrosis factor alpha -308G/A polymorphism with the risk of diabetes in an elderly population-based cohort. Genes and Immunity 2002, 3:225-228.
13. Hermann S.M., Richard S., Nicaud V., et al. Polymorphisms of the tumour necrosis factor-α gene, coronary heart disease and obesity. European Journal of Clinical Investigation 1998, 28:59-66.
14. Joint International Society and Federation of Cardiology/World Health Organization Task Force Nomenclature and criteria for diagnosis of ischemic heart disease. Circulation 1979, 59:607-609.
15. Jones K.G., Brull D.J., Brown L.C., et al. Interleukin-6 (IL-6) and the prognosis of abdominal aortic aneurysms. Circulation 2001, 103:2260-2265.
16. Jones K.G., Brull D.J., Brown L.C., Sian M., Greenhalgh R.M., Humphries S.E., Powell J.T. Interleukin-6 (IL-6) and the prognosis of abdominal aortic aneurysms. Circulation 2001, 103:2260-2265.
17. Kelberman D., Hawe E., Luong L.A., Mohamed-Ali V., et al. Effect of Interleukin-6 promoter polymorphisms in survivors of myocardial infarction and matched controls in the North and South of Europe. The HIFMECH Study. Thrombosis and Haemostasis 2004, 92:1122-1128.
18. Kim J.M., Brannan C.I., Copeland N.G., Jenkins N.A., Khan T.A., Moore K.W. Structure of the mouse IL-10 gene and chromosomal localization of the mouse and human genes. Journal of Immunology 1992, 148:3618-3623.
19. Koch W., Kastrati A., Bottiger C., Mehilli J., von Beckerath N., Schomig A. Interleukin-10 and tumor necrosis factor gene polymorphisms and risk of coronary artery disease and myocardial infarction. Atherosclerosis 2001, 159:137-144.
20. Kube D., Rieth H., Eskdale J., Kremsner P.G., Gallagher G. Structural characterization of the distal 5' flanking region of the human interleukin-10 gene. Genes and Immunity 2001, 2:181-190.
21. Kubota T., McNamara D.M., Wang J.J., et al. Effects of tumor necrosis factor gene polymorphisms on patients with congestive heart failure. Circulation 1998, 97:2499-2501.
22. Leeder S., Raymond S., Greenberg H., Liu H., Esson K. A Race against Time: The Challenge of Cardiovascular Disease in Developing Countries 2004, Trustees of Columbia University, New York.
23. Libby P. Inflammation in atherosclerosis. Nature 2002, 420:868-874.
24. Lieb W., Pavlik R., Erdmann J., et al. No association of interleukin-6 gene. Polymorphism (-174G/C) with myocardial infarction or traditional cardiovascular risk factors. International Journal of Cardiology 2004, 97:205-212.
25. Lio D., Candore G., Crivello A., et al. Opposite effects of interleukin 10 common gene polymorphisms in cardiovascular diseases and in successful ageing: genetic background of male centenarians is protective against coronary heart disease. Journal of Medical Genetics 2004, 41:790-794.
26. Nauck M., Winkelmann B.R., Hoffmann M.M., Böhm B.O., Wieland H., März W. The interleukin-6G(-174)C promoter polymorphism in the LURIC cohort: no association with plasma interleukin-6, coronary artery disease, and myocardial infarction. Journal of Molecular Medicine 2002, 80:507-513.
27. Okopien B., Haberka M., Cwalina L., et al. Plasma cytokines as predictors of coronary heart disease. Research Communications in Molecular Pathology and Pharmacology 2002, 112:5-15.
28. Padovani J.C., Pazin-Filho A., Simoes M.V., Marin-Neto J.A., Zago M.A., Franco R.F. Gene polymorphisms in the TNF locus and the risk of myocardial infarction. Thrombosis Research 2000, 100:263-269.
29. Pola R., Flex A., Gaetani E., Flore R., Serricchio M., Pola P. Synergistic effect of -174G/C polymorphism of the interleukin-6 gene promoter and 469 E/K polymorphism of the intercellular adhesion molecule-1 gene in Italian patients with history of ischemic stroke. Stroke 2003, 34:881-885.
30. Schippers E.F., van't Veer C., van Voorden S., et al. IL-10 and toll-like receptor-4 polymorphisms and the in vivo and ex vivo response to endotoxin. Cytokine 2005, 29:215-228.
31. Seino Y., Ikeda U., Ikeda M., Yamamoto K., et al. Interleukin 6 gene transcripts are expressed in human atherosclerotic lesions. Cytokine 1994, 6:87-91.
32. Seljeflot I., Hurlen M., Solheim S., Arnesen H. Serum levels of interleukin-10 are inversely related to future events in patients with acute myocardial infarction. Journal of Thrombosis and Haemostasis 2004, 2:350-352.
33. Stuber F., Udalova I.A., Book M., et al. -308 tumor necrosis factor (TNF) polymorphism is not associated with survival in severe sepsis and is unrelated to lipopolysaccharide inducibility of the human TNF promoter. Journal of Inflammation 1996, 46:42-50.
34. Suarez A., Castro P., Alonso R., Mozo L., Gutiérrez C. Interindividual variations in constitutive interleukin-10 messenger RNA and protein levels and their association with genetic polymorphisms. Transplantation 2003, 75:711-717.
35. Sukovich D.A., Kauser K., Shirley F.D., Del Vecchio V., Halks-Miller M., Rubanyi G.M. Expression of interleukin-6 in atherosclerotic lesions of male ApoE-knockout mice: inhibition by 17beta-estradiol. Arteriosclerosis, Thrombosis, and Vascular Biology 1998, 18:1498-1505.
36. Tedgui A., Mallat Z. Anti-inflammatory mechanisms in the vascular wall. Circulation Research 2001, 88:877-887.
37. Trompet S., Pons D., DE Craen A.J., et al. Genetic variation in the interleukin-10 gene promoter and risk of coronary and cerebrovascular events: the PROSPER study. Annals of the New York Academy of Sciences 2007, 1100:189-198.
38. Turner D.M., Williams D.M., Sankaran D., Lazarus M., Sinnott P.J., Hutchinson I.V. An investigation of polymorphism in the interleukin-10 gene promoter. European Journal of Immunogenetics 1997, 24:1-8.
39. Vendrell J., Fernandez-Real J.M., Gutierrez C., et al. A polymorphism in the promoter of the tumor necrosis factor-alpha gene (-308) is associated with coronary heart disease in type 2 diabetic patients. Atherosclerosis 2003, 167:257-264.
40. -308→A polymorphism and risk for coronary artery disease. Clinical Science 2000, 98:435-437.
41. Wilson A.G., di Giovine F.S., Duff G.W. Genetics of tumour necrosis factor-α in autoimmune, infectious, and neoplastic diseases. Journal of Inflammation 1995, 45:1-12.
42. Wilson A.G., Symons J.A., McDowell T.L., McDevitt H.O., Duff G.W. Effects of a polymorphism in the human tumor necrosis factor α promoter on transcriptional activation. Proceedings of the National Academy of Sciences 1997, 94:3195-3199.
43. Wojakowski W., Maslankiewicz K., Ochala A., et al. The pro- and anti-inflammatory markers in patients with acute myocardial infarction and chronic stable angina. International Journal of Molecular Medicine 2004, 14:317-322.
44. Woodward M., Rumley A., Tunstall-Pedoe H., Lowe G.D.O. Associations of blood rheology and interleukin-6 with cardiovascular risk factors and prevalent cardiovascular disease. British Journal of Haematology 1999, 104:246-257.